Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Caribou Biosciences (CRBU) Debt to Equity (2020)

Caribou Biosciences (CRBU) has disclosed Debt to Equity for 1 consecutive years, with -$0.04 as the latest value for Q4 2020.

  • On a quarterly basis, Debt to Equity changed N/A to -$0.04 in Q4 2020 year-over-year; TTM through Dec 2020 was -$0.04, a N/A change, with the full-year FY2020 number at -$0.04, changed N/A from a year prior.
  • Debt to Equity was -$0.04 for Q4 2020 at Caribou Biosciences.
  • In the past five years, Debt to Equity ranged from a high of -$0.04 in Q4 2020 to a low of -$0.04 in Q4 2020.